Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 19(23): 6565-70, 2009 Dec 01.
Article in English | MEDLINE | ID: mdl-19854054

ABSTRACT

Novel bi-functional compounds with a nitric oxide (NO)-releasing moiety bound to a dorzolamide scaffold were investigated. Several compounds were synthesized and their activity as selective carbonic anhydrase inhibitors (CAI) evaluated in vitro on recombinant hCA type I, II and IV enzyme isoforms where they showed different degrees of potency and selectivity to hCA II. A high resolution X-ray crystal structure for the CA II adduct with 8 confirmed the high affinity of this class of compounds for the enzyme. Compounds 4, 6, and 8 showed highly potent and efficacious NO-mediated properties as assessed by their vascular relaxant effect on methoxamine-precontracted rabbit aortic rings. Finally, compounds 4 and 6 exerted potent intraocular pressure (IOP) lowering effects in vivo in normotensive rabbits thereby anticipating their potential for the treatment of hypertensive glaucoma.


Subject(s)
Carbonic Anhydrase II/antagonists & inhibitors , Carbonic Anhydrase Inhibitors/therapeutic use , Glaucoma, Open-Angle/drug therapy , Nitric Oxide/chemistry , Sulfonamides/therapeutic use , Thiophenes/therapeutic use , Animals , Carbonic Anhydrase Inhibitors/chemical synthesis , Carbonic Anhydrase Inhibitors/chemistry , Crystallography, X-Ray , Drug Discovery , Models, Molecular , Molecular Structure , Rabbits , Structure-Activity Relationship , Sulfonamides/chemical synthesis , Sulfonamides/chemistry , Thiophenes/chemical synthesis , Thiophenes/chemistry
2.
3.
J Med Chem ; 49(11): 3362-7, 2006 Jun 01.
Article in English | MEDLINE | ID: mdl-16722655

ABSTRACT

Gonadotropin releasing hormone (GnRH) plays an important role in the biology of reproduction. The use of GnRH receptor antagonists has been reported in the literature for the treatment of breast, ovarian, and prostate cancers. In this article, we report the synthesis, in vitro characterization, pharmacokinetics, and pharmacodynamics of an orally bioavailable, potent, small molecule GnRH receptor antagonist N-{4,6-dimethoxy-2-[(3-morpholin-4-ylpropyl)amino]pyrimidin-5-yl}-5-[3,3,6-trimthyl-2,3-dihydro-1H-inden-5-yl)oxy]-2-furamide (compound 1).


Subject(s)
Indenes/chemical synthesis , Morpholines/chemical synthesis , Pyrimidines/chemical synthesis , Receptors, LHRH/antagonists & inhibitors , Administration, Oral , Animals , Biological Availability , Humans , In Vitro Techniques , Indenes/chemistry , Indenes/pharmacology , Inositol Phosphates/biosynthesis , Male , Morpholines/chemistry , Morpholines/pharmacology , Orchiectomy , Pituitary Gland/metabolism , Pyrimidines/chemistry , Pyrimidines/pharmacology , Radioligand Assay , Rats , Rats, Sprague-Dawley , Recombinant Proteins/metabolism , Structure-Activity Relationship , Testis/drug effects , Testis/metabolism , Testosterone/antagonists & inhibitors , Testosterone/metabolism
4.
J Org Chem ; 68(2): 267-75, 2003 Jan 24.
Article in English | MEDLINE | ID: mdl-12530848

ABSTRACT

A new one-pot nitration employing tetramethylammonium nitrate and trifluoromethanesulfonic anhydride in dichloromethane to provide a ready source of the nitronium triflate nitrating agent is presented. Rapid and selective nitration with a variety of aromatic and heteroaromatic substrates is achieved resulting in the synthesis of several novel organic compounds. A distinct advantage is the removal of undesired byproducts by aqueous workup. This very mild nitration permits large-scale syntheses and gives high isolated product yields that often require no further purification. This tetramethylammonium nitrate-based nitration also has been applied to microwave-assisted conditions, and the results with several compounds are outlined.

SELECTION OF CITATIONS
SEARCH DETAIL
...